Katrin Hücking

Degradation of Endogenous and Exogenous Gastric Inhibitory Polypeptide in Healthy and in Type 2 Diabetic Subjects as Revealed Using a New Assay for the Intact Peptide¹

Carolyn F. Deacon, Michael A. Nauck, Juris J. Meier et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 399 citations · Full text

Immunology, Gastroenterology, Gip Metabolism +25

Reduced Insulinotropic Effect of Gastric Inhibitory Polypeptide in First-Degree Relatives of Patients With Type 2 Diabetes

Juris J. Meier, Katrin Hücking, Jens J. Holst et al. · Diabetes · 2001 · 228 citations

Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs

Marilyn Ader, Stella P. Kim, Karyn J. Catalano et al. · Diabetes · 2005 · 165 citations · Full text

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

Michael A. Nauck, A. El-Ouaghlidi, Bartholomäus Gabrys et al. · Regulatory Peptides · 2004 · 136 citations

Metabolic Syndrome, Medicine, Diabetes +9

Burst-like control of lipolysis by the sympathetic nervous system in vivo

Katrin Hücking, Marianthe Hamilton-Wessler, Martin Ellmerer et al. · Journal of Clinical Investigation · 2003 · 90 citations · Full text